Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.
2.
3.

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f. Review.

PMID:
18480677
4.

[Hereditary basis of attention deficit and hyperactivity disorder].

Manor I, Ebstein R.

Harefuah. 2000 Nov;139(9-10):382-5. Review. Hebrew. No abstract available.

PMID:
11341221
5.

[Neuropsychopharmacological effects of methylphenidate].

Ikeda K, Takamatsu Y, Hagino Y, Sora I.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Jun;29(3):121-3. Review. Japanese.

PMID:
19663262
6.

Genetic polymorphisms of serotonin and dopamine transporters in mental disorders.

Ueno S.

J Med Invest. 2003 Feb;50(1-2):25-31. Review.

PMID:
12630565
7.

Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD.

Swanson JM, Volkow ND.

Behav Brain Res. 2002 Mar 10;130(1-2):73-8. Review.

PMID:
11864720
8.

Molecular genetics of attention-deficit/hyperactivity disorder.

Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P.

Biol Psychiatry. 2005 Jun 1;57(11):1313-23. Epub 2005 Jan 21. Review.

PMID:
15950004
9.

A review of the biological bases of ADHD: what have we learned from imaging studies?

Durston S.

Ment Retard Dev Disabil Res Rev. 2003;9(3):184-95. Review.

PMID:
12953298
10.

The dopamine transporter and attention-deficit/hyperactivity disorder.

Madras BK, Miller GM, Fischman AJ.

Biol Psychiatry. 2005 Jun 1;57(11):1397-409. Epub 2005 Jan 5. Review.

PMID:
15950014
11.

Attention deficit and hyperactivity disorder: review of genetic association studies.

Galili-Weisstub E, Segman RH.

Isr J Psychiatry Relat Sci. 2003;40(1):57-66. Review.

PMID:
12817670
12.

Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.

Contini V, Rovaris DL, Victor MM, Grevet EH, Rohde LA, Bau CH.

Eur Neuropsychopharmacol. 2013 Jun;23(6):555-60. doi: 10.1016/j.euroneuro.2012.05.006. Epub 2012 Jun 17. Review.

PMID:
22709890
13.

Genetics of the serotonergic system in suicidal behavior.

Arango V, Huang YY, Underwood MD, Mann JJ.

J Psychiatr Res. 2003 Sep-Oct;37(5):375-86. Review.

PMID:
12849930
14.

Molecular genetic studies of ADHD: 1991 to 2004.

Bobb AJ, Castellanos FX, Addington AM, Rapoport JL.

Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):109-25. Review.

PMID:
15700344
15.

Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002.

Rapoport JL, Inoff-Germain G.

J Atten Disord. 2002;6 Suppl 1:S57-60. Review.

PMID:
12685519
16.

Serum and brain concentrations of methylphenidate: implications for use and abuse.

Swanson JM, Volkow ND.

Neurosci Biobehav Rev. 2003 Nov;27(7):615-21. Review.

PMID:
14624806
17.

[Distribution of DRD4 and DAT1 alleles from dopaminergic system in a mixed Chilean population].

Vieyra G, Moraga M, HenrĂ­quez H, Aboitiz F, Rothhammer F.

Rev Med Chil. 2003 Feb;131(2):135-43. Review. Spanish.

PMID:
12708251
18.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

19.

A current update on ADHD pharmacogenomics.

Kieling C, Genro JP, Hutz MH, Rohde LA.

Pharmacogenomics. 2010 Mar;11(3):407-19. doi: 10.2217/pgs.10.28. Review.

PMID:
20235795
20.

Attention deficit hyperactivity disorder: unravelling the molecular genetics.

Thapar A.

Mol Psychiatry. 1998 Sep;3(5):370-2. Review. No abstract available.

PMID:
9774767

Supplemental Content

Support Center